(MUR) Murphy Oil - Overview
Stock: Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.17% |
| Yield on Cost 5y | 13.45% |
| Yield CAGR 5y | 26.98% |
| Payout Consistency | 69.6% |
| Payout Ratio | 76.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 48.3% |
| Relative Tail Risk | -4.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 4.61 |
| Character TTM | |
|---|---|
| Beta | 1.563 |
| Beta Downside | 2.221 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.46% |
| CAGR/Max DD | -0.10 |
Description: MUR Murphy Oil January 11, 2026
Murphy Oil Corporation (NYSE:MUR) is a vertically integrated upstream firm that explores for and produces crude oil, natural gas, and natural gas liquids across the United States, Canada, and select international assets. Founded in 1950 and renamed in 1964, the company is headquartered in Houston, Texas, and trades as a common stock within the GICS sub-industry “Oil & Gas Exploration & Production.”
Key operating metrics as of the latest 2023 annual report show average daily production of roughly 115,000 barrels of oil equivalent (BOE), with a 2022-2023 cash flow conversion of about 1.2 ×, and a net debt-to-EBITDA ratio near 2.0×, indicating moderate leverage relative to peers. The firm’s earnings are highly sensitive to U.S. shale price dynamics and the broader natural-gas market, which is driven by seasonal demand, LNG export capacity, and OPEC-plus production decisions.
If you want to dig deeper into Murphy Oil’s valuation and scenario analysis, the ValueRay platform offers a data-rich toolkit that can help you assess upside and downside risks.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 104.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -12.04 > 1.0 |
| NWC/Revenue: -5.72% < 20% (prev -5.22%; Δ -0.50% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.25b > Net Income 104.2m |
| Net Debt (1.82b) to EBITDA (1.25b): 1.46 < 3 |
| Current Ratio: 0.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (144.0m) vs 12m ago -1.89% < -2% |
| Gross Margin: 71.85% > 18% (prev 0.33%; Δ 7152 % > 0.5%) |
| Asset Turnover: 27.89% > 50% (prev 31.22%; Δ -3.34% > 0%) |
| Interest Coverage Ratio: 2.83 > 6 (EBITDA TTM 1.25b / Interest Expense TTM 96.1m) |
Altman Z'' 3.48
| A: -0.02 (Total Current Assets 907.3m - Total Current Liabilities 1.06b) / Total Assets 9.83b |
| B: 0.68 (Retained Earnings 6.73b / Total Assets 9.83b) |
| C: 0.03 (EBIT TTM 272.1m / Avg Total Assets 9.75b) |
| D: 1.11 (Book Value of Equity 5.12b / Total Liabilities 4.60b) |
| Altman-Z'' Score: 3.48 = A |
Beneish M 1.00
| DSRI: 1.16 (Receivables 283.7m/272.5m, Revenue 2.72b/3.02b) |
| GMI: 0.46 (GM 71.85% / 33.19%) |
| AQI: 16.51 (AQ_t 0.09 / AQ_t-1 0.01) |
| SGI: 0.90 (Revenue 2.72b / 3.02b) |
| TATA: -0.12 (NI 104.2m - CFO 1.25b) / TA 9.83b) |
| Beneish M-Score: 5.62 (Cap -4..+1) = D |
What is the price of MUR shares?
Over the past week, the price has changed by +6.71%, over one month by +5.14%, over three months by +16.02% and over the past year by +28.59%.
Is MUR a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 13
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the MUR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.6 | -4.7% |
| Analysts Target Price | 30.6 | -4.7% |
| ValueRay Target Price | 35.2 | 9.7% |
MUR Fundamental Data Overview January 31, 2026
P/E Forward = 57.4713
P/S = 1.614
P/B = 0.8667
P/EG = 0.3062
Revenue TTM = 2.72b USD
EBIT TTM = 272.1m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 1.43b USD (from longTermDebt, two quarters ago)
Short Term Debt = 281.3m USD (from shortTermDebt, last quarter)
Debt = 2.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b USD (from netDebt column, last quarter)
Enterprise Value = 6.17b USD (4.34b + Debt 2.20b - CCE 377.0m)
Interest Coverage Ratio = 2.83 (Ebit TTM 272.1m / Interest Expense TTM 96.1m)
EV/FCF = 15.56x (Enterprise Value 6.17b / FCF TTM 396.4m)
FCF Yield = 6.43% (FCF TTM 396.4m / Enterprise Value 6.17b)
FCF Margin = 14.58% (FCF TTM 396.4m / Revenue TTM 2.72b)
Net Margin = 3.83% (Net Income TTM 104.2m / Revenue TTM 2.72b)
Gross Margin = 71.85% ((Revenue TTM 2.72b - Cost of Revenue TTM 765.2m) / Revenue TTM)
Gross Margin QoQ = none% (prev 66.05%)
Tobins Q-Ratio = 0.63 (Enterprise Value 6.17b / Total Assets 9.83b)
Interest Expense / Debt = 1.03% (Interest Expense 22.8m / Debt 2.20b)
Taxrate = 40.82% (71.9m / 176.1m)
NOPAT = 161.1m (EBIT 272.1m * (1 - 40.82%))
Current Ratio = 0.85 (Total Current Assets 907.3m / Total Current Liabilities 1.06b)
Debt / Equity = 0.43 (Debt 2.20b / totalStockholderEquity, last quarter 5.12b)
Debt / EBITDA = 1.46 (Net Debt 1.82b / EBITDA 1.25b)
Debt / FCF = 4.60 (Net Debt 1.82b / FCF TTM 396.4m)
Total Stockholder Equity = 5.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.07% (Net Income 104.2m / Total Assets 9.83b)
RoE = 2.03% (Net Income TTM 104.2m / Total Stockholder Equity 5.14b)
RoCE = 4.15% (EBIT 272.1m / Capital Employed (Equity 5.14b + L.T.Debt 1.43b))
RoIC = 2.44% (NOPAT 161.1m / Invested Capital 6.61b)
WACC = 7.96% (E(4.34b)/V(6.54b) * Re(11.68%) + D(2.20b)/V(6.54b) * Rd(1.03%) * (1-Tc(0.41)))
Discount Rate = 11.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.70%
[DCF Debug] Terminal Value 78.45% ; FCFF base≈859.5m ; Y1≈870.3m ; Y5≈944.9m
Fair Price DCF = 104.4 (EV 16.72b - Net Debt 1.82b = Equity 14.89b / Shares 142.7m; r=7.96% [WACC]; 5y FCF grow 0.94% → 2.90% )
EPS Correlation: -80.58 | EPS CAGR: -35.62% | SUE: 1.01 | # QB: 2
Revenue Correlation: -86.42 | Revenue CAGR: -7.82% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.24 | Chg30d=-0.285 | Revisions Net=-5 | Analysts=12
EPS current Year (2026-12-31): EPS=1.27 | Chg30d=-0.555 | Revisions Net=-7 | Growth EPS=-7.4% | Growth Revenue=-10.1%
EPS next Year (2027-12-31): EPS=2.06 | Chg30d=-0.908 | Revisions Net=-6 | Growth EPS=+62.1% | Growth Revenue=+18.8%